Total Payments
$851.35
2024 Payments
$117.61
Companies
13
Transactions
78
Medicare Patients
4,601
Medicare Billing
$436,907
Payment Breakdown by Category
Food & Beverage$846.66 (99.4%)
Education$4.69 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $846.66 | 77 | 99.4% |
| Education | $4.69 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $428.92 | 53 | $0 (2022) |
| Merck Sharp & Dohme LLC | $114.76 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $71.08 | 5 | $0 (2024) |
| Amgen Inc. | $38.02 | 2 | $0 (2023) |
| Edwards Lifesciences Corporation | $37.43 | 1 | $0 (2024) |
| Novo Nordisk Inc | $35.30 | 2 | $0 (2021) |
| Phathom Pharmaceuticals, Inc. | $22.96 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $21.69 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.63 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $16.49 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.61 | 6 | AstraZeneca Pharmaceuticals LP ($43.00) |
| 2023 | $75.95 | 5 | AstraZeneca Pharmaceuticals LP ($28.08) |
| 2022 | $115.20 | 6 | PFIZER INC. ($37.96) |
| 2021 | $111.15 | 7 | Merck Sharp & Dohme Corporation ($41.30) |
| 2020 | $29.29 | 2 | Merck Sharp & Dohme Corporation ($17.19) |
| 2019 | $76.29 | 6 | PFIZER INC. ($60.74) |
| 2018 | $198.59 | 31 | PFIZER INC. ($175.93) |
| 2017 | $127.27 | 15 | PFIZER INC. ($127.27) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $37.43 | General |
| 09/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | ROTATEQ (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: VACCINE | ||||||
| 07/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.60 | General |
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Respiratory | ||||||
| 12/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Inflammation | ||||||
| 08/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: RESPIRATORY | ||||||
| 01/06/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: WOMENS HEALTH | ||||||
| 12/29/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $37.96 | General |
| Category: VACCINES | ||||||
| 12/01/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), VAXNEUVANCE, VAXELIS | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: VACCINE | ||||||
| 09/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardio-renal | ||||||
| 07/28/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 04/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/28/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), VAXNEUVANCE, VAXELIS | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: VACCINE | ||||||
| 10/01/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Diabetes | ||||||
| 07/19/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: RESPIRATORY | ||||||
| 09/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,021 | 1,602 | $187,687 | $98,924 |
| 2022 | 21 | 1,113 | 1,809 | $196,424 | $108,364 |
| 2021 | 21 | 1,180 | 1,930 | $191,541 | $120,035 |
| 2020 | 19 | 1,287 | 1,935 | $189,963 | $109,584 |
Total Patients
4,601
Total Services
7,276
Medicare Billing
$436,907
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 241 | 430 | $69,379 | $32,261 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 215 | 438 | $49,841 | $23,753 | 47.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 178 | 178 | $35,867 | $21,720 | 60.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 73 | 74 | $6,260 | $5,255 | 83.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 75 | 75 | $2,550 | $2,151 | 84.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $3,111 | $2,005 | 64.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 14 | 14 | $2,184 | $1,831 | 83.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 29 | $2,895 | $1,769 | 61.1% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 14 | 59 | $3,157 | $1,369 | 43.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 33 | $1,747 | $1,263 | 72.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 24 | 28 | $2,120 | $1,054 | 49.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 21 | 37 | $1,891 | $989.76 | 52.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 16 | $1,128 | $778.54 | 69.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $1,203 | $743.64 | 61.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 24 | $1,663 | $731.69 | 44.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 20 | $1,343 | $707.94 | 52.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $476.00 | $401.52 | 84.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 18 | 22 | $169.70 | $79.20 | 46.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 78 | $702.00 | $60.79 | 8.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 268 | 546 | $88,065 | $39,884 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 177 | 177 | $26,116 | $22,148 | 84.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 208 | 384 | $43,652 | $20,573 | 47.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 94 | 95 | $7,125 | $6,492 | 91.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 94 | 94 | $2,584 | $2,374 | 91.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $2,666 | $2,093 | 78.5% |
About Dr. J Huser, M.D
Dr. J Huser, M.D is a Family Medicine healthcare provider based in Weatherford, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699750554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. J Huser, M.D has received a total of $851.35 in payments from pharmaceutical and medical device companies, with $117.61 received in 2024. These payments were reported across 78 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($846.66).
As a Medicare-enrolled provider, Huser has provided services to 4,601 Medicare beneficiaries, totaling 7,276 services with total Medicare billing of $436,907. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Weatherford, OK
- Active Since 12/13/2005
- Last Updated 12/11/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1699750554
Products in Payments
- CHANTIX (Drug) $254.85
- VIAGRA (Drug) $68.96
- ELIQUIS (Drug) $62.46
- FARXIGA (Drug) $41.92
- BELSOMRA (Drug) $41.30
- PREVNAR 20 (Biological) $37.96
- Ozempic (Drug) $35.30
- GARDASIL 9 (Biological) $26.50
- VOQUEZNA (Drug) $22.96
- Repatha (Biological) $22.66
- ENTRESTO (Drug) $21.69
- STIOLTO RESPIMAT (Drug) $19.63
- JANUVIA (Drug) $17.19
- TRELEGY ELLIPTA (Drug) $16.49
- LILETTA (Drug) $16.02
- BREZTRI (Drug) $15.56
- STEGLATRO (Drug) $15.55
- Otezla (Drug) $15.36
- Kerendia (Drug) $15.32
- ROTATEQ (Biological) $14.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weatherford
Adam Khadbai, M.d, M.D
Family Medicine — Payments: $18,816
Family Medicine $18,816
Rupa Pachigolla, M.d, M.D
Family Medicine — Payments: $9,183
Family Medicine $9,183
Steven Melcher, M.d, M.D
Family Medicine — Payments: $5,814
Family Medicine $5,814
Robert Miller, Md, MD
Family Medicine — Payments: $5,529
Family Medicine $5,529
Dr. Blake Badgett, M.d, M.D
Family Medicine — Payments: $4,884
Family Medicine $4,884
Miguel Gutierrez, Md, MD
Family Medicine — Payments: $4,767
Family Medicine $4,767